Steven R. Pacelli

Insider Reports History

Reporting-owner location: San Diego, CA
Latest reporting-owner signature: By: Jereme Sylvain For: Steven R Pacelli
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Steven R. Pacelli

Form 4 holding EVP Managing Director Dexcom V

DEXCOM INC

Security class: Common Stock
Shares / value: 124,775
Estimated value: $15,426,532
Report date: 24 Nov 2023
Price: $123.63
Ownership: Direct

Form 4 holding Director

ProSomnus, Inc.

Security class: Common Stock
Shares / value: 18,200
Estimated value: $15,561
Report date: 06 Dec 2022
Price: $0.8550
Ownership: Direct

Insider Reports Filed by Steven R. Pacelli

4 DXCM

DEXCOM INC

Report period: 24 Nov 2023
Transactions: 1
Transaction value: -$45,539
Accepted by SEC: 27 Nov 2023, 16:00
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Oct 2023
Transactions: 1
Transaction value: -$35,243
Accepted by SEC: 23 Oct 2023, 19:43
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 22 Sep 2023
Transactions: 1
Transaction value: -$36,332
Accepted by SEC: 22 Sep 2023, 18:30
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Aug 2023
Transactions: 1
Transaction value: -$43,989
Accepted by SEC: 23 Aug 2023, 17:42
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 24 Jul 2023
Transactions: 1
Transaction value: -$53,799
Accepted by SEC: 24 Jul 2023, 17:18
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 14 Jul 2023
Transactions: 1
Transaction value: -$684,216
Accepted by SEC: 17 Jul 2023, 16:54
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Jun 2023
Transactions: 1
Transaction value: -$51,879
Accepted by SEC: 26 Jun 2023, 16:16
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 May 2023
Transactions: 1
Transaction value: -$48,884
Accepted by SEC: 23 May 2023, 19:13
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 27 Apr 2023
Transactions: 1
Transaction value: -$633,906
Accepted by SEC: 27 Apr 2023, 18:38
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 24 Apr 2023
Transactions: 1
Transaction value: -$51,368
Accepted by SEC: 26 Apr 2023, 16:36
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Mar 2023
Transactions: 1
Transaction value: -$633,449
Accepted by SEC: 27 Mar 2023, 17:08
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 10 Mar 2023
Transactions: 3
Transaction value: -$1,299,915
Accepted by SEC: 14 Mar 2023, 16:46
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 08 Mar 2023
Transactions: 1
Transaction value: +$18.78
Accepted by SEC: 10 Mar 2023, 14:58
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Feb 2023
Transactions: 1
Transaction value: -$45,996
Accepted by SEC: 23 Feb 2023, 17:34
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4

ProSomnus, Inc.

Report period: 30 Jan 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Feb 2023, 18:33
Role: Director
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Jan 2023
Transactions: 1
Transaction value: -$44,438
Accepted by SEC: 24 Jan 2023, 15:16
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Dec 2022
Transactions: 1
Transaction value: -$46,379
Accepted by SEC: 27 Dec 2022, 15:29
Role: EVP Managing Director Dexcom V
Next action: Open filing details

3/A

ProSomnus, Inc.

Report period: 06 Dec 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 16 Feb 2024, 18:01
Role: Director
Next action: Open filing details

3

ProSomnus, Inc.

Report period: 06 Dec 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 07 Dec 2022, 08:42
Role: Director
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Aug 2022
Transactions: 1
Transaction value: -$84,210
Accepted by SEC: 24 Aug 2022, 17:25
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 25 Jul 2022
Transactions: 1
Transaction value: -$83,070
Accepted by SEC: 25 Jul 2022, 18:00
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Jun 2022
Transactions: 1
Transaction value: -$72,550
Accepted by SEC: 27 Jun 2022, 16:46
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 24 May 2022
Transactions: 1
Transaction value: -$74,082
Accepted by SEC: 25 May 2022, 16:44
Role: EVP Managing Director Dexcom V
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 25 Apr 2022
Transactions: 1
Transaction value: -$109,985
Accepted by SEC: 27 Apr 2022, 17:47
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Mar 2022
Transactions: 1
Transaction value: -$114,995
Accepted by SEC: 24 Mar 2022, 16:35
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 08 Mar 2022
Transactions: 4
Transaction value: -$1,392,363
Accepted by SEC: 10 Mar 2022, 18:27
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Feb 2022
Transactions: 1
Transaction value: -$98,582
Accepted by SEC: 24 Feb 2022, 16:45
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 24 Jan 2022
Transactions: 1
Transaction value: -$104,192
Accepted by SEC: 26 Jan 2022, 15:27
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Dec 2021
Transactions: 1
Transaction value: -$143,478
Accepted by SEC: 23 Dec 2021, 16:29
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 14 Dec 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 16 Dec 2021, 18:44
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Nov 2021
Transactions: 1
Transaction value: -$153,065
Accepted by SEC: 23 Nov 2021, 17:51
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 22 Oct 2021
Transactions: 1
Transaction value: -$142,500
Accepted by SEC: 25 Oct 2021, 19:35
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Sep 2021
Transactions: 8
Transaction value: -$3,866,020
Accepted by SEC: 24 Sep 2021, 20:01
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 09 Sep 2021
Transactions: 2
Transaction value: -$683,747
Accepted by SEC: 13 Sep 2021, 20:00
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Aug 2021
Transactions: 4
Transaction value: -$556,678
Accepted by SEC: 25 Aug 2021, 16:59
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Jul 2021
Transactions: 2
Transaction value: -$487,897
Accepted by SEC: 27 Jul 2021, 18:03
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 23 Jun 2021
Transactions: 3
Transaction value: -$460,651
Accepted by SEC: 24 Jun 2021, 17:59
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

4 DXCM

DEXCOM INC

Report period: 24 May 2021
Transactions: 7
Transaction value: -$376,260
Accepted by SEC: 26 May 2021, 16:57
Role: Managing Dir., Dexcom Ventures
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .